If there is any area of the lab in which the term revolutionary rightly is being applied, it has to be for rapid pathogen identification. This juggernaut of change has profound implications for patient outcomes, the cost and efficiency of care, lab practice, and, most significantly, global antimicrobial stewardship efforts.

"If we can't rapidly determine whether someone does or does not have an infection and then whether their infection is bacterial or viral, we'll continue to see widespread use of antibiotics, at times in very inappropriate ways," explained Angela Caliendo, MD, PhD, chief of general internal medicine at Rhode Island Hospital and executive vice chair of medicine at The Warren Alpert Medical School at Brown University in Providence. "Rapid diagnostics really are a game-changer by helping us determine earlier in a patient's presentation the need―or not―for antibiotics so we can start implementing treatment modalities that change outcomes. There are all sorts of ways you can see it coming together."

Anchor BioResearch is at the forefront of prophylactic diagnostics by testing our clients for harmful and deadly respiratory, pneumonia, and gastrointestinal infectious diseases. We offer the gold standard for testing syndromic infectious delivering accurate actionable results within hours.